PharmaShots | Incisive News in 3 Shots

Subscribe Now

regains

Reata Regains Exclusive Worldwide Rights of its Nrf2 Activator Product Platform from AbbVie

Reata Regains Exclusive Worldwide Rights of its Nrf2 Activator Product Platform from AbbVie

October 10, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us